(NASDAQ: EMBC) Embecta's forecast annual revenue growth rate of 3.35% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.47%.
Embecta's revenue in 2026 is $1,018,700,000.On average, 6 Wall Street analysts forecast EMBC's revenue for 2026 to be $59,039,302,158, with the lowest EMBC revenue forecast at $56,364,969,085, and the highest EMBC revenue forecast at $60,965,728,524. On average, 6 Wall Street analysts forecast EMBC's revenue for 2027 to be $62,608,856,895, with the lowest EMBC revenue forecast at $59,945,855,742, and the highest EMBC revenue forecast at $64,591,942,860.
In 2028, EMBC is forecast to generate $63,118,793,286 in revenue, with the lowest revenue forecast at $60,229,153,737 and the highest revenue forecast at $65,555,156,043.